Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its effectiveness in another group of patients with the bleeding disorder. That's ...

NEW YORK (Reuters) -Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical industry needs to collaborate with China’s, where speedy processes have vaulted it to 30% of ...

Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified healthcare portfolios. J&J operates primarily through its pharmaceuticals ...

Pfizer and Astellas Pharma said a treatment for certain bladder-cancer patients demonstrated positive topline results in a Phase 3 study. In the trial, the combination of Padcev with Merck & Co.'s ...

Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about a year. This time, the drug that delivered the positive readout is Tukysa, ...

The world’s biggest pharma companies recorded their best weekly performance in years on Friday after Pfizer (NYSE:PFE) reached a landmark drug pricing deal with the U.S. government, agreeing to sell ...

Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 19, Pfizer Inc. (NYSE:PFE) and Astellas Pharma US Inc. announced final overall survival results from ...

Texas's top prosecutor on Wednesday announced the state had reached a $41.5 million settlement with US drugmakers Pfizer and Tris Pharma, over allegations of drug adulteration and defrauding the state ...

The Trump administration announced an agreement with Pfizer and unveiled a major drug pricing plan Tuesday, in which the pharma giant will sell its drugs at lower prices based on Most Favored Nation ...

Orient Pharma was hit with a patent infringement lawsuit on June 16 in Delaware District Court over its attempt to market generic versions of Pfizer's Xeljanz XR treatment for autoimmune conditions.